Compounds > 7-hydroxy-2-n,n-dipropylaminotetralin
Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Dyskinesia, Medication-Induced

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Dyskinesia, Medication-Induced in 1 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sánchez-Pernaute, R1
Jenkins, BG1
Choi, JK1
Iris Chen, YC1
Isacson, O1

Other Studies

1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Dyskinesia, Medication-Induced

ArticleYear
In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.
    Neurobiology of disease, 2007, Volume: 27, Issue:2

    Topics: Animals; Brain; Cerebrovascular Circulation; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Ma

2007